VivoSeq
Other

Cataplexy

4

Pipeline Programs↗

0

Active Trials↗

2

Companies Involved↗

Cataplexy is an early-stage landscape with 4 programs across 2 companies. The most active players are Harmony Biosciences Management, Inc., Jazz Pharmaceuticals. 3 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

H

Harmony Biosciences Management, Inc.

1 program

Phase 3Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

3

clinical trials

Completed3 · 100%

Clinical Trials

Trial Activity

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
Completed·BBioprojet·Phase 3·NCT01067235·14 enrolled
Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Completed·BBioprojet·Phase 3·NCT02611687·110 enrolled
Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
Completed·BBioprojet·Phase 3·NCT01800045·103 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)